Insider Trading March 18, 2026

HF Foods CAO Adds 4,000 Shares as Company Posts Modest Revenue Gain

Christine Chang increased her stake in HF Foods Group Inc. in a March Form 4 filing; recent quarterly results show revenue growth amid macroeconomic pressure

By Maya Rios HFFG
HF Foods CAO Adds 4,000 Shares as Company Posts Modest Revenue Gain
HFFG

Christine Chang, Chief Administrative Officer of HF Foods Group Inc (NASDAQ: HFFG), bought 4,000 shares of the company’s common stock on March 18, 2026, at $1.7399 per share, a transaction valued at $6,959. The purchase was disclosed in a Form 4 filed with the Securities and Exchange Commission. Following the trade, Chang’s direct holdings total 237,995 shares. HF Foods recently reported Q4 2025 net revenue of $1.23 billion, a 2.2% year-over-year increase driven by higher volumes and pricing improvements in key categories. The stock was trading at $1.86 and is down 48% over the past six months, while some analysts retain a $7 price target. According to InvestingPro analysis, HFFG appears undervalued at current levels.

Key Points

  • Christine Chang, CAO of HF Foods, purchased 4,000 shares at $1.7399 per share on March 18, 2026, totaling $6,959.
  • Following the purchase, Chang directly owns 237,995 shares of HF Foods Group Inc.
  • HF Foods reported Q4 2025 net revenue of $1.23 billion, a 2.2% increase year-over-year, driven by volume increases and pricing improvements.

Christine Chang, the Chief Administrative Officer of HF Foods Group Inc (NASDAQ:HFFG), executed an insider purchase on March 18, 2026, acquiring 4,000 shares of the company’s common stock, according to a Form 4 filing with the Securities and Exchange Commission. The shares were purchased at $1.7399 each, producing a total transaction value of $6,959.

After recording the transaction, Chang directly holds 237,995 shares of HF Foods Group Inc. The filing specifies the details of the purchase but does not include any accompanying commentary from the insider.

Market context provided in the filing and subsequent market data show the company’s stock trading at $1.86 at the time of reporting. That price represents a 48% decline over the preceding six months. Despite the recent price weakness, the article notes that analysts continue to maintain a $7 price target for the shares.

Investor research referenced in the filing points to InvestingPro analysis, which characterizes HFFG as appearing undervalued at current price levels. The availability of a Pro Research Report covering HFFG and more than 1,400 U.S. equities is noted for investors seeking further details.


Recent financial performance

HF Foods reported results for the fourth quarter of 2025 that indicate modest revenue growth despite broader economic challenges. Net revenue rose by 2.2% year-over-year to $1.23 billion. The company attributes this increase to a combination of higher volumes and pricing improvements across key product categories.

The company’s statement on the quarter did not highlight any material mergers or acquisitions, and there were no analyst upgrades or downgrades reported alongside the quarterly release. The report emphasizes steadiness in financial performance in the face of difficult macroeconomic conditions, without projecting future outcomes.


What the filings and results show

  • The Form 4 documents an insider buy by Christine Chang of 4,000 shares at $1.7399 per share on March 18, 2026, totaling $6,959.
  • Chang’s direct ownership now stands at 237,995 shares.
  • HF Foods posted Q4 2025 net revenue of $1.23 billion, a 2.2% year-over-year increase attributed to volume and pricing gains.
  • The stock price cited is $1.86 and has declined 48% over the past six months, while some analysts retain a $7 target.

The information included here is drawn from the SEC filing reporting the insider transaction and the company’s earnings disclosure for Q4 2025. No additional corporate actions, analyst rating changes, or M&A activity were reported in the recent disclosures.

Risks

  • Share price volatility - the stock traded at $1.86 and has fallen 48% over the past six months, indicating market risk for equity investors.
  • Macroeconomic uncertainty - the company noted challenging macroeconomic conditions that could continue to affect performance.
  • Limited analyst movement - no analyst upgrades or downgrades were reported in the recent updates, which may constrain near-term market re-rating.

More from Insider Trading

Foxx Development CEO Disposes of $30,436 in Stock; Board Addition and Meeting Clarification Also Filed Mar 18, 2026 IRadimed CEO Disposes $762,970 in Stock as Shares Trade Near Yearly Peak Mar 18, 2026 Harvard Bioscience Director Increases Stake with $48,700 Purchase Mar 18, 2026 Babcock & Wilcox CEO Increases Stake With $106,015 Market Purchase; Earlier Option Exercise and RSU Grant Expanded Holdings Mar 18, 2026 Babcock & Wilcox CFO Makes Purchase, Exercises RSUs as Company Posts Q4 Beat Mar 18, 2026